Drug
Azimilide clinical trials
How studies write it
Studies that test it under each name
Name
- Azimilide Dihydrochloride
- 7
Studies by the year they started
7 studies that test it; most in 2000 (2)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
Studies
Open first, then newest update. How each study uses azimilide is read from its arms, and is right about nine times in ten.
Testing it · 7
- Effect of Azimilide Dihydrochloride on Renal FunctionCompletedPhase 1Forest LaboratoriesNCT00318838Written as Azimilide dihydrochloride
- Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)CompletedPhase 3Forest LaboratoriesNCT00751738Written as azimilide dihydrochloride
- Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)TerminatedPhase 3Forest LaboratoriesNCT01464476Written as Azimilide Dihydrochloride
- Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.CompletedPhase 3Forest LaboratoriesNCT00035464Written as Azimilide Dihydrochloride
- Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter DefibrillatorsCompletedPhase 3Forest LaboratoriesNCT00035490Written as Azimilide Dihydrochloride
- Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.CompletedPhase 3Forest LaboratoriesNCT00035451Written as Azimilide Dihydrochloride
- Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial FibrillationCompletedPhase 3Forest LaboratoriesNCT00035477Written as Azimilide Dihydrochloride
Codes
What other systems call azimilide · ClinicalTrials.gg INT003775
- MeSH (NLM) C086123azimilideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 74QU6P2934AZIMILIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q553161azimilideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79923AzimilideOne source FDA
- DrugBank DB04957One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C086123 | azimilide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 74QU6P2934 | AZIMILIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q553161 | azimilide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79923 | Azimilide | One source FDA |
| DrugBank | DB04957 | — | One source Wikidata |
Also registered as azimilide dihydrochloride (UNII 6E6VJP68KR).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.